Who
Steven H. Nelson
Director
Company insider
Files Form 4 as: Director, Health Catalyst; EVP and President, Aetna, CVS Health; EVP & CEO, UnitedHealthcare, UnitedHealth Group; Director, NeurogesX; President Health Net of the NE, Health Net.
In numbers
- Trades disclosed
- 84
- Buys
- 1
- Sells
- 6
- Bought
- $2,578
- Sold
- $16.2M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 11 Apr 2006
- Last trade
- 16 Jul 2026
- Last filed
- 20 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 20 Jul 2026 | HCAT Health CatalystIT Services & Consulting | SEC FORM 4 Code A | —80,691 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | HCAT Health CatalystIT Services & Consulting | SEC FORM 4 Code A | —80,691 at $0.00 | filing |
| 1 May 2026filed 4 May 2026 | HCAT Health CatalystIT Services & Consulting | SEC FORM 4 Code A | —154,808 at $0.00 | filing |
| 1 May 2026filed 4 May 2026 | HCAT Health CatalystIT Services & Consulting | SEC FORM 4 Code A | —154,808 at $0.00 | filing |
| 1 Apr 2026filed 2 Apr 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code F | $176K2,432 at $72.49 | filing |
| 1 Apr 2026filed 2 Apr 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code F | $176K2,432 at $72.49 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $1.6M22,277 at $71.82 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $10.3M143,712 at $71.82 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $10.3M143,712 at $71.82 | filing |
| 31 Mar 2026filed 2 Apr 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $1.6M22,277 at $71.82 | filing |
| 1 Apr 2025filed 3 Apr 2025 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $6.1M90,455 at $67.98 | filing |
| 1 Apr 2025filed 3 Apr 2025 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Code A | $1.4M21,329 at $67.98 | filing |
| 23 Jan 2025filed 27 Jan 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Bought | $1,28924 at $53.70 | filing |
| 23 Jan 2025filed 27 Jan 2026 | CVS CVS HealthMass, Grocery & Drug Retail | SEC FORM 4 Bought | $1,28924 at $53.70 | filing |
| 30 Nov 2024filed 3 Dec 2024 | CVS CVS Healthoption or derivative · Mass, Grocery & Drug Retail | SEC FORM 4 Code A | $8.9M124,378 at $71.82 | filing |
| 25 Jun 2019filed 27 Jun 2019 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —76.1 at $0.00 | filing |
| 19 Mar 2019filed 21 Mar 2019 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —60.87 at $0.00 | filing |
| 26 Feb 2019filed 28 Feb 2019 | UNH UnitedHealth Groupoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —36,074 at $0.00 | filing |
| 26 Feb 2019filed 28 Feb 2019 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code A | —22,266 at $0.00 | filing |
| 26 Feb 2019filed 28 Feb 2019 | UNH UnitedHealth GroupManaged Care & Insurers | SEC FORM 4 Code F | $2.7M10,152 at $262.98 | filing |
News
CVS Health: CVS Caremark: Why Transparency Matters in Pharmacy BenefitsCVS · finanznachrichten.de · 19 Oct 2026UnitedHealth Group (NYSE:UNH) Given New $524.00 Price Target at JPMorgan Chase & Co.UNH · tickerreport.com · 16 Oct 2026Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and moreCVS · seekingalpha.com · 16 Oct 2026CVS Health: CVS Caremark Is Transforming the Health Care ExperienceCVS · finanznachrichten.de · 16 Oct 2026UnitedHealth targets 13% to 16% long-term growth as 2026 adjusted EPS guidance moves to at least $20.50 (NYSE:UNH)UNH · seekingalpha.com · 13 Oct 2026UnitedHealth: Huge Earnings Surprise (NYSE:UNH)UNH · seekingalpha.com · 13 Oct 2026
0 headlines in the last 90 days name Steven H. Nelson; 6 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.